L72P (p.Leu72Pro) variant of CASQ2 (Calsequestrin-2)

L72P (p.Leu72Pro) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.41 / 1. The record also includes population frequency data and structural context.

L72P (p.Leu72Pro) variant details